BRISTOL, Tenn., Feb. 5, 2026 /PRNewswire/ — Kingsway Pharmaceuticals, LLC announced today that it has officially acquired the Lobe Miracle® brand from CCA IndustriesBRISTOL, Tenn., Feb. 5, 2026 /PRNewswire/ — Kingsway Pharmaceuticals, LLC announced today that it has officially acquired the Lobe Miracle® brand from CCA Industries

Kingsway Pharmaceuticals Welcomes Lobe Miracle® to Its Family of Trusted Brands

2026/02/06 00:02
2 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

BRISTOL, Tenn., Feb. 5, 2026 /PRNewswire/ — Kingsway Pharmaceuticals, LLC announced today that it has officially acquired the Lobe Miracle® brand from CCA Industries, Inc., marking a significant step in the company’s continued expansion within the consumer healthcare space. This purchase strengthens Kingsway’s portfolio of trusted, practical solutions designed to support everyday wellness needs. Lobe Miracle®, a longstanding and well‑regarded product created to improve earlobe comfort and appearance, will transition under Kingsway’s ownership effective immediately.

“For years, Lobe Miracle® has helped people feel confident and comfortable, and we’re proud to carry that purpose forward,” said Ben Blessing, COO of Kingsway Pharmaceuticals. “We see tremendous opportunity to expand awareness of this unique product, elevate its presence in the marketplace, and introduce it to new consumers who will benefit from it.”

CCA Industries expressed full support for the transition, noting Kingsway’s commitment to intentional brand stewardship and seamless integration into its product lineup. “Kingsway Pharmaceuticals has demonstrated a strong vision for the future of Lobe Miracle®,” said Chris Dominello of CCA Industries, Inc. “We are confident the brand will continue to thrive under their leadership and reach even greater potential in its next chapter.”

This acquisition underscores Kingsway Pharmaceuticals’ dedication to delivering accessible, meaningful, and consumer‑focused healthcare solutions nationwide.

About Kingsway Pharmaceuticals, LLC:

Kingsway Pharmaceuticals is a Tennessee‑based healthcare company focused on developing and marketing trusted consumer wellness products. With a growing portfolio that spans personal care, OTC solutions, and everyday health essentials, Kingsway is dedicated to delivering products that improve comfort, confidence, and quality of life for consumers nationwide. In 2023, Kingsway Pharmaceuticals purchased the Bikini Zone® brand from CCA Industries, and has sense seen a 30+% lift across the brand. Then, in 2025, Kingsway Pharmaceuticals acquired a strategic minority stake in CIGA Healthcare, a global diagnostics innovator.

www.kingswaypharma.com

About CCA Industries, Inc. (CAWW):

CCA Industries, Inc. is a long‑established consumer products company known for developing, marketing, and distributing a range of personal care, beauty, and wellness brands. With decades of experience and a strong commitment to product quality, CCA Industries has built a diverse portfolio trusted by consumers across the U.S. and internationally.

www.ccaindustries.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kingsway-pharmaceuticals-welcomes-lobe-miracle-to-its-family-of-trusted-brands-302680378.html

SOURCE Kingsway Pharmaceuticals

Opportunità di mercato
Logo Spacecoin
Valore Spacecoin (SPACE)
$0.005737
$0.005737$0.005737
+2.79%
USD
Grafico dei prezzi in tempo reale di Spacecoin (SPACE)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!